Table 2. Lung cancer subclassification using immunostaining by patients and lesions.
| Lung Cancer Type | Frontal | Parietal | Temporal | Occipital | Cerebellum | Unknown /Other | Lesions | Patients |
|---|---|---|---|---|---|---|---|---|
| Adenocarcinoma * | 59 | 31 | 14 | 21 | 37 | 2 | 164 | 152 |
| Squamous cell carcinoma ** | 8 | 5 | 5 | 8 | 1 | 0 | 27 | 23 |
| Small cell carcinoma | 6 | 4 | 0 | 2 | 17 | 1 | 30 | 28 |
| Non-small cell carcinoma NOS *** | 15 | 8 | 1 | 4 | 6 | 0 | 34 | 31 |
| Sum | 88 | 48 | 20 | 35 | 61 | 3 | 255 | 234 |
* Adenocarcinoma definition: TTF-1 positive, p63 NOT positive.
** Squamous cell carcinoma definition: TTF-1 negative, p63 positive.
*** Includes probable Large Cell Neuroendocrine Carcinoma (LCNEC).